Both sources efficiently delivered miR‐93‐5p to NSCLC cells, leading to PTEN suppression, reduced PTEN‐3′ UTR activity, and enhanced tumor aggressiveness, all of which were reversed by ASO‐miR‐93‐5p. This evidence concerns the gene PTEN and non-small cell lung carcinoma.